IRIS Accounts Production v23.2.0.158 08879844 director 1.1.22 31.12.22 31.12.22 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh088798442021-12-31088798442022-12-31088798442022-01-012022-12-31088798442020-12-31088798442021-01-012021-12-31088798442021-12-3108879844ns10:Originalns15:EnglandWales2022-01-012022-12-3108879844ns14:PoundSterlingns10:Original2022-01-012022-12-3108879844ns10:Originalns10:Director12022-01-012022-12-3108879844ns10:Original2022-01-012022-12-3108879844ns10:Original2022-12-3108879844ns10:Originalns10:PrivateLimitedCompanyLtd2022-01-012022-12-3108879844ns10:Originalns10:SmallEntities2022-01-012022-12-3108879844ns10:Originalns10:AuditExempt-NoAccountantsReport2022-01-012022-12-3108879844ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-01-012022-12-3108879844ns10:SmallCompaniesRegimeForAccountsns10:Original2022-01-012022-12-3108879844ns10:Originalns10:FullAccounts2022-01-012022-12-3108879844ns10:Originalns10:RegisteredOffice2022-01-012022-12-3108879844ns10:Original2021-12-3108879844ns10:Originalns5:CurrentFinancialInstruments2022-12-3108879844ns10:Originalns5:CurrentFinancialInstruments2021-12-3108879844ns5:ShareCapitalns10:Original2022-12-3108879844ns5:ShareCapitalns10:Original2021-12-3108879844ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3108879844ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-12-3108879844ns10:Originalns5:PlantMachinery2022-01-012022-12-3108879844ns10:Original2021-01-012021-12-3108879844ns10:Originalns5:LandBuildings2021-12-3108879844ns10:Originalns5:PlantMachinery2021-12-3108879844ns10:Original2021-12-3108879844ns10:Originalns5:LandBuildings2022-01-012022-12-3108879844ns10:Originalns5:LandBuildings2022-12-3108879844ns10:Originalns5:PlantMachinery2022-12-3108879844ns10:Originalns5:LandBuildings2021-12-3108879844ns10:Originalns5:PlantMachinery2021-12-3108879844ns10:Originalns5:UnlistedNon-exchangeTradedns5:CostValuation2021-12-3108879844ns10:Originalns5:UnlistedNon-exchangeTraded2022-12-3108879844ns10:Originalns5:UnlistedNon-exchangeTraded2021-12-3108879844ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3108879844ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2021-12-3108879844ns10:Originalns5:Non-currentFinancialInstrumentsns5:AfterOneYear2022-12-3108879844ns10:Originalns5:Non-currentFinancialInstrumentsns5:AfterOneYear2021-12-3108879844ns10:Original1ns10:Director12021-12-3108879844ns10:Original1ns10:Director12020-12-3108879844ns10:Original1ns10:Director12022-01-012022-12-3108879844ns10:Original1ns10:Director12021-01-012021-12-3108879844ns10:Original1ns10:Director12022-12-3108879844ns10:Original1ns10:Director12021-12-31
REGISTERED NUMBER: 08879844 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2022

for

Neuro-Procare Limited

Neuro-Procare Limited (Registered number: 08879844)






Contents of the Financial Statements
for the Year Ended 31 December 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Neuro-Procare Limited

Company Information
for the Year Ended 31 December 2022







DIRECTOR: Dr J P C Poupel





REGISTERED OFFICE: 6a Greys Road
Henley on Thames
Oxfordshire
RG9 1RY





REGISTERED NUMBER: 08879844 (England and Wales)





ACCOUNTANT: J N Flanagan ATT (Fellow)
The Granary,
Hones Yard,
1 Waverley Lane,
Farnham,
Surrey
GU9 8BB

Neuro-Procare Limited (Registered number: 08879844)

Balance Sheet
31 December 2022

31.12.22 31.12.21
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,370,793 2,405,447
Investments 5 27,200 27,200
2,397,993 2,432,647

CURRENT ASSETS
Debtors 6 235,000 150,000
Prepayments and accrued income 2,214 -
Cash at bank 341,918 315,891
579,132 465,891
CREDITORS
Amounts falling due within one year 7 62,492 47,612
NET CURRENT ASSETS 516,640 418,279
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,914,633

2,850,926

PROVISIONS FOR LIABILITIES 2,863 4,633
NET ASSETS 2,911,770 2,846,293

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 2,911,769 2,846,292
SHAREHOLDERS' FUNDS 2,911,770 2,846,293

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Neuro-Procare Limited (Registered number: 08879844)

Balance Sheet - continued
31 December 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 February 2024 and were signed by:





Dr J P C Poupel - Director


Neuro-Procare Limited (Registered number: 08879844)

Notes to the Financial Statements
for the Year Ended 31 December 2022

1. STATUTORY INFORMATION

Neuro-Procare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on cost

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2021 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 January 2022 2,532,071 102,115 2,634,186
Additions - 389 389
At 31 December 2022 2,532,071 102,504 2,634,575
DEPRECIATION
At 1 January 2022 151,010 77,729 228,739
Charge for year 25,332 9,711 35,043
At 31 December 2022 176,342 87,440 263,782
NET BOOK VALUE
At 31 December 2022 2,355,729 15,064 2,370,793
At 31 December 2021 2,381,061 24,386 2,405,447

Neuro-Procare Limited (Registered number: 08879844)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022

5. FIXED ASSET INVESTMENTS
Unlisted
investments
£   
COST
At 1 January 2022
and 31 December 2022 27,200
NET BOOK VALUE
At 31 December 2022 27,200
At 31 December 2021 27,200

6. DEBTORS
31.12.22 31.12.21
£    £   
Amounts falling due within one year:
Other debtors 15,000 -

Amounts falling due after more than one year:
Other debtors 220,000 150,000

Aggregate amounts 235,000 150,000

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.22 31.12.21
£    £   
Taxation and social security 57,801 32,469
Other creditors 4,691 15,143
62,492 47,612

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2022 and 31 December 2021:

31.12.22 31.12.21
£    £   
Dr J P C Poupel
Balance outstanding at start of year - -
Amounts advanced 15,000 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 15,000 -

The £15,000 loan to the director was repaid on 16th August 2023.